| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 431-443, Copyright © 1994 by American Society for Investigative Pathology
REVIEWS |
B Tycko
Department of Pathology, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Most genes are expressed from two alleles, one maternal and the other paternal. The term "genomic imprinting" refers to a genetic phenomenon which produces some interesting exceptions to this rule. Genes which are subject to imprinting are molecularly marked before fertilization such that they are transcriptionally silenced at one of the parental alleles in the offspring. A growing body of evidence implicates genomic imprinting in the pathogenesis of certain human genetic diseases, inherited tumor syndromes, and sporadic tumors. This review discusses examples of imprinting, theories as to why the phenomenon exists, possible molecular mechanisms of imprinting, and our current understanding of the role of imprinting in human pathology.
This article has been cited by other articles:
![]() |
W. Hartmann, A. Koch, H. Brune, A. Waha, U. Schuller, I. Dani, D. Denkhaus, W. Langmann, U. Bode, O. D. Wiestler, et al. Insulin-Like Growth Factor II Is Involved in the Proliferation Control of Medulloblastoma and Its Cerebellar Precursor Cells Am. J. Pathol., April 1, 2005; 166(4): 1153 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, H. Nagai, T. Ohno, M. Yuge, S. Hatano, E. Ito, N. Mori, H. Saito, and T. Kinoshita Aberrant DNA methylation of p57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype Blood, September 18, 2002; 100(7): 2572 - 2577. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hartmann, A. Waha, A. Koch, C. G. Goodyer, S. Albrecht, D. von Schweinitz, and T. Pietsch p57KIP2 Is Not Mutated in Hepatoblastoma but Shows Increased Transcriptional Activity in a Comparative Analysis of the Three Imprinted Genes p57KIP2, IGF2, and H19 Am. J. Pathol., October 1, 2000; 157(4): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chen, S.-M. Ip, D. Cheng, L.-C. Wong, and H. Y. S. Ngan Loss of Imprinting of the IGF-II and H19 Genes in Epithelial Ovarian Cancer Clin. Cancer Res., February 1, 2000; 6(2): 474 - 479. [Abstract] [Full Text] |
||||
![]() |
E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression Am. J. Pathol., November 1, 1998; 153(5): 1597 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Li, G. Franklin, H.-M. Cui, K. Svensson, X.-B. He, G. Adam, R. Ohlsson, and S. Pfeifer The H19 Transcript Is Associated with Polysomes and May Regulate IGF2 Expression in trans J. Biol. Chem., October 23, 1998; 273(43): 28247 - 28252. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Wang, J.-X. Duan, T. H. Vu, and A. R. Hoffman Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity J. Biol. Chem., November 1, 1996; 271(44): 27863 - 27870. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |